Education
About Us
Working with TipRanks
Follow Us
Iovance Biotherapeutics (DE:2LB)
:2LB
RESEARCH TOOLSreports
Iovance Biotherapeutics (2LB) Ownership Overview
0.30% Insiders
17.00%
Mutual Funds
0.19% Other Institutional Investors
15.54% ETFs
66.97% Public Companies and
Individual Investors
The ownership structure of Iovance Biotherapeutics (DE:2LB) stock is a mix of institutional, retail, and individual investors. Approximately 32.73% of the company’s stock is owned by Institutional Investors, 0.30% is owned by Insiders, and 66.97% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 16, 2025 | xxxxxxxxxxxxx | $42250 | |
Nov 14, 2024 | xxxxxxxxxxxxx | $503000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $407000 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $621600 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $4170469 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $163630768 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 26,099,934 | Institution | 7.96% | 81,144,695 | |
| 23,682,436 | Institution | 7.22% | 73,628,694 | |
| 22,112,266 | Institution | 6.74% | 68,747,035 | |
| 13,090,626 | Institution | 3.99% | 40,698,756 | |
| 5,728,311 | Institution | 1.75% | 17,809,319 | |
| 5,101,239 | Institution | 1.56% | 15,859,752 | |
| 2,940,670 | Institution | 0.90% | 9,142,543 | |
| 2,922,265 | Institution | 0.89% | 9,085,322 | |
| 2,274,742 | Institution | 0.69% | 7,072,173 | |
| 1,972,881 | Institution | 0.60% | 6,133,687 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 23,682,436 | Institution | 7.22% | 73,628,694 | |
| 5,101,239 | Institution | 1.56% | 15,859,752 | |
| 2,940,670 | Institution | 0.90% | 9,142,543 | |
| 2,922,265 | Institution | 0.89% | 9,085,322 | |
| 2,274,742 | Institution | 0.69% | 7,072,173 | |
| 1,886,316 | Institution | 0.58% | 5,864,556 | |
| 1,747,040 | Institution | 0.53% | 5,431,547 | |
| 1,705,320 | Institution | 0.52% | 5,301,840 | |
| 1,503,461 | Institution | 0.46% | 4,674,260 | |
| 1,445,665 | Institution | 0.44% | 4,494,572 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Iovance Biotherapeutics (DE:2LB)?
According to the latest TipRanks data, approximately 0.19% of the company's stock is held by institutional investors, 0.30% is held by insiders, and 66.97% is held by retail investors.
What percentage of Iovance Biotherapeutics (DE:2LB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.19% of Iovance Biotherapeutics (DE:2LB) stock is held by institutional investors.
What percentage of Iovance Biotherapeutics (DE:2LB) stock is held by retail investors?
According to the latest TipRanks data, approximately 66.97% of Iovance Biotherapeutics (DE:2LB) stock is held by retail investors.
Who owns the most shares of Iovance Biotherapeutics (DE:2LB)?
Vanguard owns the most shares of Iovance Biotherapeutics (DE:2LB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.